Related Experiment Video
Updated: Apr 23, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice
Jessica M Snyder1, Piper M Treuting1, Lee Nagy2
1Department of Comparative Medicine, University of Washington, Seattle, Washington, United States of America; Comparative Pathology Program, University of Washington, Seattle, Washington, United States of America.
None:
A humanized TLR7/TLR8 transgenic mouse line was engineered for studies using TLR7/8 ligands as vaccine adjuvants. The mice developed a spontaneous immune-mediated phenotype prior to six months of age characterized by runting, lethargy, blepharitis, and corneal ulceration. Histological examination revealed a marked, multisystemic histiocytic infiltrate that effaced normal architecture. The histological changes were distinct from those previously reported in mouse models of systemic lupus erythematosus. When the mice were crossed with MyD88-/- mice, which prevented toll-like receptor signaling, the inflammatory phenotype resolved. Illness may be caused by constitutive activation of human TLR7 or TLR8 in the bacterial artificial chromosome positive mice as increased TLR7 and TLR8 expression or activation has previously been implicated in autoimmune disease.

